Todd R. Brady insider trades

Open-market stock purchases and sales by Todd R. Brady, Director at Contineum Therapeutics, Inc, from SEC Form 4 filings since May 24, 2024.

Recent trades

DateStockTradeValue
Jun 26, 2026CTNM Contineum Therapeutics, IncBought (not open market)—

Companies traded

  • CTNM Contineum Therapeutics, Inc: other filings, last Jun 26, 2026

Get free alerts when Todd R. Brady files a new trade →